We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NORD: FDA’s Benefit-Risk Review Templates Lack Patient Input Process
NORD: FDA’s Benefit-Risk Review Templates Lack Patient Input Process
May 22, 2013
The FDA’s draft plan for implementing standard benefit-risk templates in drug reviews lacks a process for including patient concerns, the National Organization of Rare Diseases (NORD) says.